Abstract
Prostate-specific antigen (PSA) is well known as a specific tumor marker for prostate cancer, but carcinoembryonic antigen (CEA)- and carbohydrate antigen 19-9 (CA19-9)-elevating adenocarcinomas originating in the prostate gland are rare. We report a case of metastatic adenocarcinoma of the prostate gland with a high serum level of CEA and CA19-9 in a 78-year-old man in whom prostate cancer (T3N1M1) had been diagnosed 2 years ago and who was treated with androgen deprivation therapy. He visited the emergency department because of a loss of appetite and abdominal pain. The serum CEA and CA19-9 levels were increased to 218.9. ng/mL (normal,
Original language | English |
---|---|
Pages (from-to) | 28-30 |
Number of pages | 3 |
Journal | Urological Science |
Volume | 25 |
Issue number | 1 |
DOIs | |
Publication status | Published - Mar 2014 |
Keywords
- Carbohydrate antigen 19-9 (CA19-9)
- Carcinoembryonic antigen (CEA)
- Metastatic prostate cancer
- Tumor marker
ASJC Scopus subject areas
- Urology